Adage Capital Partners
RCKT icon

Adage Capital Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Adage Capital Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200,000
Closed -$4.31M – 926
2024
Q2 		$4.31M Buy
200,000
+70,000
+54% +$1.61M 0.01% 725
2024
Q1 		$3.5M Sell
130,000
-10,000
-7% -$284K 0.01% 734
2023
Q4 		$4.2M Buy
+140,000
New +$3.09M 0.01% 697
2019
Q3 		– Sell
-2,157,739
Closed -$32.4M – 757
2019
Q2 		$32.4M Sell
2,157,739
-242,261
-10% -$4.23M 0.08% 272
2019
Q1 		$42.1M Buy
2,400,000
+341,201
+17% +$5.39M 0.11% 230
2018
Q4 		$30.5M Buy
2,058,799
+758,799
+58% +$12.6M 0.08% 258
2018
Q3 		$32M Buy
1,300,000
+100,000
+8% +$2.17M 0.07% 302
2018
Q2 		$23.6M Buy
1,200,000
+200,000
+20% +$3.78M 0.05% 369
2018
Q1 		$18.8M Buy
1,000,000
+500,000
+100% +$8.15M 0.04% 410
2017
Q4 		$5.22M Buy
500,000
+125,000
+33% +$1.24M 0.01% 621
2017
Q3 		$2.67M Buy
375,000
+257,500
+219% +$1.18M 0.01% 661
2017
Q2 		$893K Hold
117,500
– – ﹤0.01% 684
2017
Q1 		$940K Hold
117,500
– – ﹤0.01% 682
2016
Q4 		$2.87M Hold
117,500
– – 0.01% 639
2016
Q3 		$4.46M Hold
117,500
– – 0.01% 618
2016
Q2 		$3.5M Buy
117,500
+48,750
+71% +$1.71M 0.01% 621
2016
Q1 		$2.04M Hold
68,750
– – 0.01% 645
2015
Q4 		$3.12M Hold
68,750
– – 0.01% 633
2015
Q3 		$2.58M Buy
+68,750
New +$3.16M 0.01% 663

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners's RCKT Position: Q3 2024 in Review

Adage Capital Partners sold out of Rocket Pharmaceuticals (RCKT) in Q3 2024, closing a stake of 200,000 shares — an estimated $4.31M sold.

Adage Capital Partners first reported a position in RCKT in Q3 2015 and held it in 19 quarters. The position peaked at $42.1M in Q1 2019. 191 funds tracked by Wall St. Rank hold RCKT as of Q3 2024.

  • Adage Capital Partners reported no remaining Rocket Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Adage Capital Partners sold 200,000 Rocket Pharmaceuticals shares in Q3 2024, an estimated $4.31M.
  • Adage Capital Partners first reported a position in Rocket Pharmaceuticals in Q3 2015 and held it in 19 quarters.
  • Adage Capital Partners's Rocket Pharmaceuticals position peaked at $42.1M in Q1 2019.
  • 191 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2024.

Based on Adage Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.